# A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants

> **NCT05062200** · PHASE1 · COMPLETED · sponsor: **Janssen Pharmaceutical K.K.** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-77242113
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05062200
- **Lead sponsor:** Janssen Pharmaceutical K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-25
- **Primary completion:** 2022-09-28
- **Final completion:** 2022-09-28
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05062200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05062200, "A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05062200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*